CN1160069C - 钯取代的细菌叶绿素衍生物及其应用 - Google Patents

钯取代的细菌叶绿素衍生物及其应用 Download PDF

Info

Publication number
CN1160069C
CN1160069C CNB99816058XA CN99816058A CN1160069C CN 1160069 C CN1160069 C CN 1160069C CN B99816058X A CNB99816058X A CN B99816058XA CN 99816058 A CN99816058 A CN 99816058A CN 1160069 C CN1160069 C CN 1160069C
Authority
CN
China
Prior art keywords
chemical compound
bpheid
formula
antibacterial
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB99816058XA
Other languages
English (en)
Chinese (zh)
Other versions
CN1334728A (zh
Inventor
A��л��˹��
A·谢兹
Y·萨洛蒙
A·布兰迪斯
H·谢尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Publication of CN1334728A publication Critical patent/CN1334728A/zh
Application granted granted Critical
Publication of CN1160069C publication Critical patent/CN1160069C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNB99816058XA 1998-12-09 1999-12-09 钯取代的细菌叶绿素衍生物及其应用 Expired - Lifetime CN1160069C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98403110.4 1998-12-09
EP98403110 1998-12-09

Publications (2)

Publication Number Publication Date
CN1334728A CN1334728A (zh) 2002-02-06
CN1160069C true CN1160069C (zh) 2004-08-04

Family

ID=8235584

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB99816058XA Expired - Lifetime CN1160069C (zh) 1998-12-09 1999-12-09 钯取代的细菌叶绿素衍生物及其应用

Country Status (22)

Country Link
US (1) US6569846B1 (enExample)
EP (1) EP1137411B1 (enExample)
JP (1) JP4796227B2 (enExample)
CN (1) CN1160069C (enExample)
AT (1) ATE347554T1 (enExample)
AU (1) AU771292B2 (enExample)
BR (1) BRPI9916096B8 (enExample)
CA (1) CA2353554C (enExample)
CY (1) CY1106450T1 (enExample)
DE (1) DE69934328T2 (enExample)
DK (1) DK1137411T3 (enExample)
ES (1) ES2277454T3 (enExample)
HK (1) HK1040638B (enExample)
HU (1) HU228208B1 (enExample)
IL (1) IL143591A0 (enExample)
NO (1) NO331426B1 (enExample)
NZ (1) NZ512093A (enExample)
PL (1) PL201172B1 (enExample)
PT (1) PT1137411E (enExample)
RU (1) RU2234508C2 (enExample)
SI (1) SI1137411T1 (enExample)
WO (1) WO2000033833A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897140B2 (en) * 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
EP1318807A4 (en) * 2000-08-11 2008-02-20 Ceramoptec Gmbh LIGHT-SENSITIVE OINTMENT
EP1277470A1 (fr) * 2001-07-17 2003-01-22 Steba Biotech N.V. Formulation galénique injectable pour utilisation dans un diagnostic ou une thérapie photodynamique et son procédé de préparation
CA2485224A1 (en) * 2002-05-08 2003-11-20 Yeda Research And Development Co. Ltd. Sensitized online bold-mri imaging method
JP4529344B2 (ja) * 2002-06-03 2010-08-25 ニプロ株式会社 腫瘍組織の酸素濃度を上昇させるためのポルフィリン酸素輸液製剤
WO2004002476A2 (en) 2002-06-27 2004-01-08 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
US7053210B2 (en) * 2002-07-02 2006-05-30 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
IL152900A0 (en) 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
RU2257898C1 (ru) * 2004-03-22 2005-08-10 Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" (ФГУП "ГНЦ "НИОПИК") Фотосенсибилизатор, липосомальная форма фотосенсибилизатора и способ проведения фотодинамической терапии
EP1753457B8 (en) * 2004-06-07 2016-09-21 Yeda Research And Development Co., Ltd. Cationic bacteriochlorophyll derivatives and uses thereof
GB2415372A (en) * 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
US20060222592A1 (en) * 2005-04-05 2006-10-05 Clemens Burda Nanoparticles and methods of manufacturing nanoparticles for electronic and non-electronic applications
US20110040170A1 (en) * 2008-01-28 2011-02-17 Yeda Research And Development Co., Ltd. Endoscopic imaging photodynamic therapy system and methods of use
PT2257309T (pt) 2008-02-27 2020-01-22 Yeda Res And Development Company Ltd Conjugados rgd-(bacterio)clorofila para utilização no diagnóstico de tumores compreendendo domínios necróticos
US20110070154A1 (en) * 2008-08-13 2011-03-24 Hyde Roderick A Artificial cells
GB0819594D0 (en) 2008-10-24 2008-12-03 Univ Coimbrra Process
EP2425873A1 (fr) 2010-09-07 2012-03-07 Steba Maor SA Modélisation de l'action d'une fibre optique dans un traitement par therapie photodynamique, et assistance à la planification d'un tel traitement
CN103405769A (zh) * 2013-03-07 2013-11-27 北京亿仁赛博医疗科技研发中心有限公司 光敏剂在制备治疗疾病的病毒灭活药物中的应用
WO2014140786A1 (en) 2013-03-11 2014-09-18 Steba Biotech S.A. Method for producing bacteriochlorophyll a
US10766915B2 (en) 2013-03-15 2020-09-08 Sherri Ann McFARLAND Metal-based coordination complexes as photodynamic compounds and their use
SG11201808849TA (en) 2016-04-10 2018-11-29 Yeda Res & Dev Combinational therapies for treatment of cancer comprising a bacteriochlorophyll derivative
US10933134B2 (en) 2017-03-16 2021-03-02 Memorial Sloan Kettering Cancer Center Combination therapies for treatment of cancer
IL311461B2 (en) * 2024-03-13 2026-05-01 Impact Biotech Ltd Process for preparing palladium-bacteriophophorbide derivatives and their alkali metal salts

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002962A (en) 1988-07-20 1991-03-26 Health Research, Inc. Photosensitizing agents
US5171741A (en) * 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
IL102645A (en) 1992-07-26 1998-02-22 Yeda Res & Dev Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
RU2063971C1 (ru) * 1993-11-05 1996-07-20 Московская государственная академия тонкой химической технологии им.М.В.Ломоносова Способ получения производного гематопорфирина
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
IL116126A0 (en) * 1995-11-24 1996-01-31 Yeda Res & Dev Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
NO20012807D0 (no) 2001-06-07
PT1137411E (pt) 2007-02-28
SI1137411T1 (sl) 2007-10-31
PL348201A1 (en) 2002-05-06
CA2353554A1 (en) 2000-06-15
HK1040638B (en) 2007-06-15
HUP0105411A2 (hu) 2002-04-29
BR9916096A (pt) 2001-11-13
EP1137411B1 (en) 2006-12-06
HU228208B1 (en) 2013-01-28
AU1583400A (en) 2000-06-26
NO331426B1 (no) 2011-12-27
WO2000033833A1 (en) 2000-06-15
BRPI9916096B8 (pt) 2021-05-25
DE69934328D1 (de) 2007-01-18
EP1137411A4 (en) 2003-04-23
HK1040638A1 (en) 2002-06-21
CY1106450T1 (el) 2011-10-12
US6569846B1 (en) 2003-05-27
ES2277454T3 (es) 2007-07-01
DE69934328T2 (de) 2007-07-19
EP1137411A1 (en) 2001-10-04
JP2002531497A (ja) 2002-09-24
RU2234508C2 (ru) 2004-08-20
AU771292B2 (en) 2004-03-18
PL201172B1 (pl) 2009-03-31
ATE347554T1 (de) 2006-12-15
JP4796227B2 (ja) 2011-10-19
DK1137411T3 (da) 2007-03-26
BR9916096B1 (pt) 2013-11-19
NO20012807L (no) 2001-08-08
IL143591A0 (en) 2002-04-21
CA2353554C (en) 2011-04-26
CN1334728A (zh) 2002-02-06
NZ512093A (en) 2003-04-29
HUP0105411A3 (en) 2003-12-29

Similar Documents

Publication Publication Date Title
CN1334728A (zh) 钯取代的细菌叶绿素衍生物及其应用
CN1222526C (zh) 制备合成的叶绿素或细菌叶绿素衍生物的酯交换的方法
CN1196497C (zh) 近红外荧光造影剂和荧光成像
CN1512994A (zh) 用于光动力学治疗的水溶性卟啉衍生物、其用途和制备
CN1250294C (zh) 光敏剂和及其生产方法
CN1217701C (zh) 近红外荧光造影剂和荧光成像
CN1714091A (zh) 中位取代卟啉
CN1460099A (zh) 在光化学疗法中作为光敏剂的5－氨基乙酰丙酸的酯类
CN1085211C (zh) 合成金属取代的细菌叶绿素衍生物及其应用
CN1088210A (zh) 叶绿素、细菌叶绿素衍生物，它们的制备以及含有它们的药物组合物
CN1057194A (zh) 卟啉的制备和应用
CN1874789A (zh) 用于光动力疗法的缀合物
JP2019533635A (ja) 新規なジヒドロポルフィンｅ６誘導体及びその薬学的に許容される塩、その調製方法並びに使用
CN1741801A (zh) 水溶性阴离子型细菌叶绿素衍生物及其用途
CN111925369B (zh) 一类β-咔啉氰基呋喃衍生物及其制备方法与应用
CN1914198A (zh) 大环内酯类化合物的稳定化方法
CN1272340C (zh) 齐墩果酸偶联衍生物及其药物用途
CN1247589C (zh) 具有抗血管生成活性的吲哚的三环衍生物
CN1541201A (zh) 脂族氨基取代的脱甲氧竹红菌素及其合成
CN1303999C (zh) 用于光动力诊断或治疗的可注射盖伦制剂配方及其制备方法
CN1144804C (zh) 苯并[c]喹嗪衍生物及其作为5α-还原酶抑制剂的用途
CN1788009A (zh) 硼化金属酞菁类及其制备方法,包含它们的医药组合物及其用途
CN1125023C (zh) 诱导细胞凋亡的物质
CN1823038A (zh) 双亲性三磺酸化四氮杂卟啉在医药中的光动力学应用
HK1056557B (en) Transesterification process for preparation of synthetic chlorophyll and bacteriochlorophyll derivative

Legal Events

Date Code Title Description
C06 Publication
C10 Entry into substantive examination
PB01 Publication
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term

Granted publication date: 20040804

CX01 Expiry of patent term